Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, ...

XPro™ is a next-generation, selective soluble TNF inhibitor designed to selectively neutralize soluble TNF (sTNF) and restore ...

The free virtual series extends Clinical Pathways Congress with timely insights into evidence-based pathways, value ...

Singular Research Emerging Growth & Value Leaders Webinar February 19, 2026 6:00 PM ESTCompany ParticipantsConference ...

Virtual program will deliver evidence-based learning for clinicians practicing in home-based, post-acute, and community ...

MALVERN, PA, UNITED STATES, February 19, 2026 /EINPresswire.com/ — As wound care delivery continues to expand across post-acute and transitional care settings, clinicians are se ...

SOLASCURE Ltd (SolasCure), a biotechnology company developing a novel treatment to transform chronic wound healing, today announced the successful completion of its second Phase II clinical trial, ...

Centralizing diagnostics and medications can speed care. Locating the lab and pharmacy in a central hub shortens transit time ...

Researchers have developed a battery-powered oxygen gel that accelerates the healing of chronic diabetic wounds ...

Learn the quickest way to distinguish skeletal from dental malocclusion in dogs and cats from Emily Edstrom, DVM, DAVDC.

Championing the art of documentary and impact media where creative excellence meets social resonance. These films ask a ...